ClinicalTrials.gg
CompletedNCT04241120Updated Mar 27, 2023Results posted

Feasibility Study for Treating Trichotillomania With Wearable Device and App System

An interventional study of Device and app system designed for participant to self-administer Habit Reversal Training and Reminder bracelet control condition in Trichotillomania, sponsored by HabitAware Inc.. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-27.

Sponsored by HabitAware Inc. · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 39 studies in Trichotillomania with a site in United States — 5 open to participants now, 7 under way, 1 of them phase 3. Trichotillomania · United States.

Enrollment
32nd of 37
15 · median 39
Started
2020
with 1 other
No phase
18 of 39
3 open now
Registered
28th of 39
by date
Lead sponsor
3 of 39
HabitAware Inc.

Among the 39 studies in Trichotillomania with a site in United States, this one is the 32nd largest by enrollment of the 37 interventional ones that give a count, is one of 2 that started in 2020, is one of 18 with no phase, and was the 28th registered.

Trichotillomania

48 studies on the registry are indexed under Trichotillomania; 8 are open to participants now.

Browse Trichotillomania studies →

Open to participants now

5 of the 39 studies in Trichotillomania with a site in United States are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 6 Trichotillomania studies recruiting now, 2 set no upper age limit and 4 stop at 75 or younger; 2 take children under 18; none take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Trichotillomania with a site in United States, or all of them as a file.
02

Study summary

Trichotillomania is characterized by recurrent hair pulling resulting in hair loss causing significant distress and impairment which persists despite repeated attempts to stop. Behavioral based therapies focused on increasing awareness of hair pulling followed by the use of an incompatible behavior have proven effective. In an effort to enhance awareness, a wrist worn motion detection device was created. In this study, we will test the feasibility of the HabitAware device and accompanying app as a system for delivering self-administered habit reversal training (HRT).

03

Conditions studied

  • Trichotillomania

Browse trials for

Keywords

  • Hair Pulling Disorder
  • Body-Focused Repetitive Behaviors
  • Trichotillomania
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 18 years of age or older
  2. Speak fluent English
  3. Current diagnosis of TTM
  4. Score above the normative mean on the automatic pulling subscale of the MIST-A
  5. Not on psychotropic medication or on a stable dose (i.e., same dose for past 6 weeks)

Exclusion criteria

Exclusion Criteria:

  1. Currently receiving psychotherapy
  2. Other psychiatric condition requiring more immediate care
  3. Have previously used any behavior awareness devices (e.g. Keen)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Experimental group - HabitAware condition

    This group will receive the device which alerts the participant when performing hair pulling behavior and the app which provides psychoeducation and components of Habit Reversal Training.

    Behavioral: Device and app system designed for participant to self-administer Habit Reversal Training

  • Placebo comparator
    Control group - reminder bracelet condition

    This group will receive only a device that vibrates randomly several times per hour as a reminder not to pull.

    Behavioral: Reminder bracelet control condition

Interventions

  • BehavioralDevice and app system designed for participant to self-administer Habit Reversal Training

    Participants will receive an awareness bracelet and an app that work together to implement key features of Habit Reversal Training. The participant will take part in psychoeducation, awareness training, and competing response training related to trichotillomania.

  • BehavioralReminder bracelet control condition

    Participants will receive a bracelet programmed to vibrate randomly several times per hour during waking hours. They will be instructed this is a reminder not to pull.

06

What researchers measure

Primary outcomes

  1. Percentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week.

    Measured via post-treatment surveys.

    Time frame: Four weeks

Secondary outcomes

  1. Percentage of Participants That Reported the Device >3 on a Scale of 1-5 for Accuracy.

    Measured by post treatment survey results

    Time frame: Four weeks

  2. Number of Participants That Can Implement HRT Procedures With 80% Accuracy

    Measured by trained clinician observing the participant perform the procedures

    Time frame: Four weeks

  3. Number of Participants With 30% Improvement in Clinical Symptoms

    Measured via pre- and post-treatment MGH-HPS (Massachusetts General Hospital Hair Pulling Scale) and/or NIMH-TSS (National Institute of Mental Health - Trichotillomania Symptom Severity) scores for those in the HabitAware conditions.

    Time frame: Four weeks

07

Results

Posted Mar 27, 2023

Participant flow

Participant flow — Overall Study
MilestoneExperimental Group - HabitAware ConditionControl Group - Reminder Bracelet Condition
Started105
Completed105
Not completed00

Outcome measures

PrimaryPercentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week.

Measured via post-treatment surveys.

Time frame:
Four weeks
Reported as:
Count of participants · Participants
Percentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week.
ParticipantsExperimental Group - HabitAware ConditionControl Group - Reminder Bracelet Condition
Percentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week.90
SecondaryPercentage of Participants That Reported the Device >3 on a Scale of 1-5 for Accuracy.

Measured by post treatment survey results

Time frame:
Four weeks
Reported as:
Count of participants · Participants
Percentage of Participants That Reported the Device >3 on a Scale of 1-5 for Accuracy.
ParticipantsExperimental Group - HabitAware ConditionControl Group - Reminder Bracelet Condition
Percentage of Participants That Reported the Device >3 on a Scale of 1-5 for Accuracy.100
SecondaryNumber of Participants That Can Implement HRT Procedures With 80% Accuracy

Measured by trained clinician observing the participant perform the procedures

Time frame:
Four weeks
Reported as:
Count of participants · Participants
Number of Participants That Can Implement HRT Procedures With 80% Accuracy
ParticipantsExperimental Group - HabitAware ConditionControl Group - Reminder Bracelet Condition
Number of Participants That Can Implement HRT Procedures With 80% Accuracy40
SecondaryNumber of Participants With 30% Improvement in Clinical Symptoms

Measured via pre- and post-treatment MGH-HPS (Massachusetts General Hospital Hair Pulling Scale) and/or NIMH-TSS (National Institute of Mental Health - Trichotillomania Symptom Severity) scores for those in the HabitAware conditions.

Time frame:
Four weeks
Reported as:
Count of participants · Participants
Number of Participants With 30% Improvement in Clinical Symptoms
ParticipantsExperimental Group - HabitAware ConditionControl Group - Reminder Bracelet Condition
Number of Participants With 30% Improvement in Clinical Symptoms63

Adverse events

Collected over 8 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Experimental Group - HabitAware Condition0/10 (0%)0/10 (0%)0/10 (0%)
Control Group - Reminder Bracelet Condition0/5 (0%)0/5 (0%)0/5 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Experimental Group - HabitAware ConditionControl Group - Reminder Bracelet ConditionTotal
Mean39.5 ± 15.531.2 ± 7.636.7 ± 13.7
Sex: Female, Male
Sex: Female, Male(Participants)Experimental Group - HabitAware ConditionControl Group - Reminder Bracelet ConditionTotal
Female10515
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Experimental Group - HabitAware ConditionControl Group - Reminder Bracelet ConditionTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White8513
More than one race202
Unknown or Not Reported000
08

Study locations

1 site
  • HabitAware, Inc.
    Saint Louis Park, Minnesota 55426, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in Mar 2020, 1 month.

Results were first posted in Mar 2023, 3 years after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2020
First posted
Jan 27, 2020
StartActual
Jan 16, 2020
Primary completionActual
Mar 4, 2020
CompletionActual
Mar 4, 2020
Results first posted
Mar 27, 2023
Last update
Mar 27, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04241120
Lead sponsor
HabitAware Inc.
Collaborators
Marquette University, National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Jan 27, 2020
Start date
Jan 16, 2020
Primary completion
Mar 4, 2020
Completion
Mar 4, 2020
Results posted
Mar 27, 2023
Last update
Mar 27, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion